Aridis Pharmaceuticals Inc. Stock News

Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of 13.73% and 40.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Aridis Pharmaceuticals Inc''s (NASDAQ: ARDS ) fully human monoclonal antibodies (mAbs) in the AR-701 cocktail has been shown to neutralize the SARS-CoV-2 omicron variant . Both mAbs conferred complete protection against Omicron infected animals when given either parenterally or by intranasal administration. Both mAbs in the AR-701 cocktail, i.e., AR-720 and AR-703, … Full story available on Benzinga.com

Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. 10x Genomics (TXG) -16%. iSpecimen ISPC -10%.

As far as short squeeze stocks go, these five companies top the list in terms of both short interest and borrow fee rates right now. The post Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Thin

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

Are these short squeeze penny stocks on our watch list right now? The post 4 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information

Aridis Pharmaceuticals ARDS +27%. Galapagos GLPG +16%. Immix Biopharma IMMX +15%. Epizyme (EPZM) -34%. Cue Biopharma (CUE) -16%.

The Bill & Melinda Gates Foundation has granted $1.9 million to Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) to evaluate Aridis'' inhaled monoclonal antibodies (mAbs) against influenza and COVID-19 for low- and middle-income countries. The mAbs will be manufactured using a spirulina-based platform technology developed by Lumen Bioscience. Lumen Bio''s platform can produce therapeutic proteins at lower costs than conventional Full story available on Benzinga.com

The stock price of Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) increased by over 30% during intraday trading today. This is why it happened.

Gainers: Exterran EXTN +51%.Aridis Pharmaceuticals (ARDS) +36%.Kohl''s KSS +31%.ShiftPixy PIXY +31%.G Medical Innovations GMVD +14%.Hall of Fame (HOFV) +14%.Shineco SISI +12%.Atlas…

Thanks to continued fear and uncertainty, the stock market is down again… The post 4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks,

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?

Aridis Pharmaceuticals Inc (ARDS) shares closed this week 26.9% lower than it did at the end of last week. The stock is currently down 28.1% year-to-date, down 73.2% over the past 12 months, and down 87.1% over the past five years. This week, the Dow Jones Industrial Average fell 1.3%, and the S&P 500 fell 2.6%. Trading Activity Shares traded as high as $2.32 and as low as $1.56 this week.Trading volume this week was 11.4% lower than the 10-day average and 83.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1434.7% The company's stock price performance over the past 12 months lags the peer average by 710.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Aridis Pharmaceuticals Inc (ARDS) shares closed today 11.8% lower than it did at the end of yesterday. The stock is currently down 26.2% year-to-date, down 71.3% over the past 12 months, and down 86.8% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $2.42 and as low as $1.69 this week.Shares closed 79.7% below its 52-week high and 1.8% above its 52-week low.Trading volume this week was 59.3% lower than the 10-day average and 84.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 9946.0% The company's stock price performance over the past 12 months lags the peer average by 715.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Aridis Pharmaceuticals Inc (ARDS) shares closed today at 1.8% above its 52 week low of $1.69, giving the company a market cap of $24M. The stock is currently down 26.2% year-to-date, down 71.3% over the past 12 months, and down 86.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 84.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 9946.0% The company's stock price performance over the past 12 months lags the peer average by 715.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.